265 results on '"Jewett, Michael A.S."'
Search Results
2. 2022 Global patient survey: Reported experience of diagnosis, management, and burden of renal cell carcinomas.
3. A phase II clinical study of intravesical photo dynamic therapy in patients with BCG-unresponsive NMIBC (interim analysis).
4. Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy
5. Treatment of localized renal cell cancer
6. A Phase 1b Clinical Study of Intravesical Photodynamic Therapy in Patients with Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer
7. A Clinical Decision Aid to Support Personalized Treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-institutional Competing-risks Analysis
8. Updated testicular cancer consensus guideline is a concise, balanced, and practical guide for clinicians
9. Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients
10. From Basic Science to Clinical Translation in Kidney Cancer: A Report from the Second Kidney Cancer Research Summit
11. Patient-centered care can be improved by joint meetings between cancer patient group leaders and health care providers
12. Patient-reported experience of diagnosis, management, and burden of renal cell carcinomas: Results >2,000 patients in 41 countries, with focus on older patients.
13. Evidence-based Urology: Trustworthy Guidelines
14. Predicting Disease Recurrence, Early Progression, and Overall Survival Following Surgical Resection for High-risk Localized and Locally Advanced Renal Cell Carcinoma
15. Utility of Serum miR-371a-3p in Predicting Relapse on Surveillance in Patients with Clinical Stage I Testicular Germ Cell Cancer
16. PROSPER: Phase III RandOmized Study Comparing PERioperative nivolumab versus observation in patients with renal cell carcinoma (RCC) undergoing nephrectomy (ECOG-ACRIN EA8143).
17. Assessment of the alignment between research funding allocation and consensus research priority areas in kidney cancer.
18. Patient-reported experience of diagnosis, management, and burden of renal cell carcinomas: Results from the 2020 Global Patient Survey from 41 countries.
19. Natural History of Renal Angiomyolipoma Favors Surveillance as an Initial Approach
20. Long-term Surveillance of Patients with Complete Response Following Chemotherapy for Metastatic Nonseminomatous Germ Cell Tumor
21. Pathologic concordance of resected metastatic nonseminomatous germ cell tumors in the chest
22. FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?†
23. Clinical dilemmas in local and regional testis cancer
24. Small Renal Mass Surveillance: Histology-specific Growth Rates in a Biopsy-characterized Cohort
25. Discrepancy in pathology reports upon second review of radical orchiectomy specimens for testicular germ cell tumors
26. Shared decision-making for the management of small renal masses — development and acceptability testing of a novel patient decision aid
27. Controversies in the management of clinical stage 1 testis cancer
28. Psychological distress associated with active surveillance in patients younger than 70 with a small renal mass
29. PROSPER: Phase III randomized study comparing perioperative nivolumab versus observation in patients with renal cell carcinoma (RCC) undergoing nephrectomy (ECOG-ACRIN EA8143).
30. PD19-07 ROLE OF LACTATE DEHYDROGENASE (LDH) IN IDENTIFYING RELAPSE FOR PATIENTS WITH STAGE I TESTIS CANCER ON ACTIVE SURVEILLANCE
31. Simultaneous Vs Sequential Retroperitoneal, Thoracic and Cervical Resection of Post Chemotherapy Residual Masses in Patients With Metastatic Nonseminomatous Germ Cell Tumors of the Testis
32. Required efficacy for novel therapies in BCG‐unresponsive non‐muscle invasive bladder cancer: Do current recommendations really reflect clinically meaningful outcomes?
33. WATChmAN: A randomized trial of virtual surveillance versus standard in-person care for clinical stage I testicular cancer.
34. A novel clinical decision aid to support personalized treatment selection for patients with CT1 renal cortical masses: Results from a multi-institutional competing risks analysis including performance status and comorbidity.
35. Prognostic urinary miRNAs for the assessment of small renal masses
36. Identification of Prognostic Biomarkers in the Urinary Peptidome of the Small Renal Mass
37. Re: Adam C. Calaway, Lawrence H. Einhorn, Timothy A. Masterson, Richard S. Foster, Clint Cary. Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular Cancer. Eur Urol 2019;76:607–9
38. Development and acceptability testing of a patient decision aid for individuals with localized renal masses considering surgical removal with partial or radical nephrectomy
39. A Canadian approach to the regionalization of testis cancer: A review
40. Identification of tumor size as the only factor associated with non-diagnostic biopsies in patients with small renal masses
41. Optimal Management of High-risk Stage I Nonseminomatous Germ Cell Tumor: Surveillance is the Preferred Option
42. Predicting Renal Cancer Recurrence: Defining Limitations of Existing Prognostic Models With Prospective Trial-Based Validation
43. Comprehensive characterization of a Canadian cohort of von Hippel‐Lindau disease patients
44. Treatment of Relapse of Clinical Stage I Nonseminomatous Germ Cell Tumors on Surveillance
45. Detection of Relapse by Low-dose Computed Tomography During Surveillance in Stage I Testicular Germ Cell Tumours
46. Patient-reported experience of diagnosis, management, and burden of renal cell carcinomas: Results from a global patient survey in forty-three countries.
47. MP14-18 AN ANATOMIC CLASSIFICATION SYSTEM FOR LOCAL RECURRENCE FOLLOWING RESECTION OF INTERMEDIATE AND HIGH RISK NON-METASTATIC RENAL CELL CARCINOMA: AN ANALYSIS OF THE ASSURE (ECOG-ACRIN 2805) TRIAL
48. Germ Cell Testicular Tumors—Contemporary Diagnosis, Staging and Management of Localized and Advanced disease
49. Kidney Cancer Research Network of Canada (KCRNC) consensus statement on the role of cytoreductive nephrectomy for patients with metastatic renal cell carcinoma
50. A New Model to Predict Benign Histology in Residual Retroperitoneal Masses After Chemotherapy in Nonseminoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.